{'52WeekChange': -0.27843136,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Building 3',
 'address2': 'Suite 200 6836 Bee Cave Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.9,
 'askSize': 900,
 'averageDailyVolume10Day': 235050,
 'averageVolume': 358506,
 'averageVolume10days': 235050,
 'beta': 1.348731,
 'beta3Year': None,
 'bid': 1.84,
 'bidSize': 900,
 'bookValue': 1.717,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.95,
 'dayLow': 1.8,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.295,
 'enterpriseToRevenue': None,
 'enterpriseValue': 15910196,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '855-298-2020',
 'fiftyDayAverage': 2.3848572,
 'fiftyTwoWeekHigh': 5.48,
 'fiftyTwoWeekLow': 0.69,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 33559935,
 'forwardEps': -1.12,
 'forwardPE': -1.6428572,
 'fromCurrency': None,
 'fullTimeEmployees': 42,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.1573,
 'heldPercentInstitutions': 0.43802,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1493337600,
 'lastSplitFactor': '0:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/savarapharma.com',
 'longBusinessSummary': 'Savara Inc. operates as an orphan lung disease '
                        'company. Its lead product candidate includes '
                        'Molgradex, an inhaled granulocyte-macrophage '
                        'colony-stimulating factor, which is in Phase III '
                        'development stage for the treatment of autoimmune '
                        'pulmonary alveolar proteinosis; and in Phase IIa '
                        'development stage for treating nontuberculous '
                        'mycobacterial lung infection. The company is also '
                        'developing AeroVanc, an inhaled vancomycin that is in '
                        'Phase III stage for the treatment of '
                        'methicillin-resistant Staphylococcus aureus lung '
                        'infection in individuals living with cystic fibrosis. '
                        'Savara Inc. is headquartered in Austin, Texas.',
 'longName': 'Savara Inc.',
 'market': 'us_market',
 'marketCap': 96024264,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_59211637',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -81482000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.92,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '512-961-1891',
 'previousClose': 1.95,
 'priceHint': 4,
 'priceToBook': 1.0716366,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.95,
 'regularMarketDayLow': 1.8,
 'regularMarketOpen': 1.92,
 'regularMarketPreviousClose': 1.95,
 'regularMarketPrice': 1.92,
 'regularMarketVolume': 278214,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 52187100,
 'sharesPercentSharesOut': 0.0464,
 'sharesShort': 2420723,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2273026,
 'shortName': 'Savara, Inc.',
 'shortPercentOfFloat': 0.047199998,
 'shortRatio': 4.87,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'SVRA',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.796,
 'twoHundredDayAverage': 2.496331,
 'volume': 278214,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.savarapharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78746'}